Search research articles
Contact Us
Filters
Showing results (71-80 of 158) with videos related to
Page
of 16
Sort By:
Exploratory Research in Clinical and Social Pharmacy
|
December 22, 2025
Unmet information needs and knowledge gaps in cancer patients undergoing oral anticancer therapy
Anna K Moritz, Wolfgang Fehrmann, Markus K Schuler, et al.
Journal of Geriatric Oncology
|
August 30, 2025
Interprofessional, risk-adapted medication management in older patients with cancer (IrMa)
Julia Thevissen, Marie-Therese Schmitz, Matthias Schmid, et al.
Biochemical Pharmacology
|
November 14, 2006
Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells
Jochen Zisowsky, Susanne Koegel, Stefan Leyers, et al.
Anti-Cancer Drugs
|
January 19, 2005
The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines
Martina Heim, Mariam Scharifi, Jochen Zisowsky, et al.
Medizinische Monatsschrift Fur Pharmazeuten
|
January 22, 2010
[Pharmaceutical care of an osteoporosis patient with hypothyroidism]
Rebekka Heumüller, Inga Kretschmer, Nele Döhler, et al.
Journal of Inorganic Biochemistry
|
March 24, 2009
Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands
Patricia Marqués-Gallego, Ganna V Kalayda, Ulrich Jaehde, et al.
Deutsches Arzteblatt International
|
November 29, 2016
Interprofessional Medication Management in Patients With Multiple Morbidities
Juliane Köberlein-Neu, Hugo Mennemann, Stefanie Hamacher, et al.
Clinical Pharmacokinetics
|
February 1, 2015
Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
Silke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Clinical Pharmacokinetics
|
June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Jan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
European Journal of Clinical Pharmacology
|
December 12, 2007
Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity
Tobias Klaassen, Alexander Jetter, Dorota Tomalik-Scharte, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 158) with videos related to
Sort By:
Page
of 16
Exploratory Research in Clinical and Social Pharmacy
|
December 22, 2025
Unmet information needs and knowledge gaps in cancer patients undergoing oral anticancer therapy
Anna K Moritz, Wolfgang Fehrmann, Markus K Schuler, et al.
Journal of Geriatric Oncology
|
August 30, 2025
Interprofessional, risk-adapted medication management in older patients with cancer (IrMa)
Julia Thevissen, Marie-Therese Schmitz, Matthias Schmid, et al.
Biochemical Pharmacology
|
November 14, 2006
Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells
Jochen Zisowsky, Susanne Koegel, Stefan Leyers, et al.
Anti-Cancer Drugs
|
January 19, 2005
The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines
Martina Heim, Mariam Scharifi, Jochen Zisowsky, et al.
Medizinische Monatsschrift Fur Pharmazeuten
|
January 22, 2010
[Pharmaceutical care of an osteoporosis patient with hypothyroidism]
Rebekka Heumüller, Inga Kretschmer, Nele Döhler, et al.
Journal of Inorganic Biochemistry
|
March 24, 2009
Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands
Patricia Marqués-Gallego, Ganna V Kalayda, Ulrich Jaehde, et al.
Deutsches Arzteblatt International
|
November 29, 2016
Interprofessional Medication Management in Patients With Multiple Morbidities
Juliane Köberlein-Neu, Hugo Mennemann, Stefanie Hamacher, et al.
Clinical Pharmacokinetics
|
February 1, 2015
Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
Silke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Clinical Pharmacokinetics
|
June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Jan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
European Journal of Clinical Pharmacology
|
December 12, 2007
Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity
Tobias Klaassen, Alexander Jetter, Dorota Tomalik-Scharte, et al.
Page
of 16